Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WDR53 pseudogene 1 (WDR53P1) is classified as a pseudogene in the human genome, meaning it is a genetic element that resembles a known gene (WDR53) but does not encode a functional protein[3][7]. Pseudogenes are typically remnants of duplicated or mutated genes and are generally not transcribed or translated into active proteins. There is no evidence that WDR53P1 plays a direct role in biological functions, disease processes, or therapeutic strategies. It is not a receptor, enzyme, transporter, or transcription factor, and accordingly is not considered a drug target or biomarker. No drugs or mechanisms of action are associated with WDR53P1[3][7]. If you meant to refer to the functional gene WDR53 (WD repeat-containing protein 53), that is a protein-coding gene, but WDR53P1 is specifically documented in genetic databases as a pseudogene, without known biological or clinical relevance as a target[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WDR53 pseudogene 1 (WDR53P1).